RT Journal Article
SR Electronic
T1 Is mammography screening beneficial: An individual-based stochastic model for breast cancer incidence and mortality
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.30.20019596
DO 10.1101/2020.01.30.20019596
A1 Le, Thuy T. T.
A1 Adler, Frederick R.
YR 2020
UL http://medrxiv.org/content/early/2020/02/03/2020.01.30.20019596.abstract
AB BACKGROUND The benefits of mammography screening have been controversial, with conflicting findings from various studies.METHODS We hypothesize that unmeasured heterogeneity in tumor aggressiveness underlies these conflicting results. Based on published data from the Canadian National Breast Screening Study (CNBSS), we develop and parameterize an individual-based mechanistic model for breast cancer incidence and mortality that tracks five stages of breast cancer progression and incorporates the effects of age on breast cancer incidence and all-cause mortality.RESULTS The model accurately reproduces the reported outcomes of the CNBSS. By varying parameters, we predict that the benefits of mammography depend on the effectiveness of cancer treatment and tumor.CONCLUSIONS In particular, patients with the most rapidly growing or potentially largest tumors have the highest benefit and least harm from the screening, with only a relatively small effect of age. However, the model predicts that confining mammography populations with a high risk of acquiring breast cancer increases the screening benefit only slightly compared with the full population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH/NCI U54 grant CA209978Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA